Clinical Trial Update: Effectiveness of REBOA in Reducing Blood Loss During Cesarean Section in Patients with PAS [NA]

View source ↗

Summary

Clinical trial evaluating REBOA to reduce blood loss during cesarean section in placenta accreta spectrum; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Placenta Accreta Spectrum

Snippet

Sponsor: Nazarbayev University | Conditions: Placenta Accreta Spectrum | NA | Status: NOT_YET_RECRUITING